FDA Clearance Tracker · P970004-S187
VERIFY EVALUATION SYSTEM FOR INTERSTIM THERAPY FOR URINARY CONTROL AND BOWEL CONTROL
Last checked: Nov 20, 2026Latest source record: Jun 26, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Jun 26, 2015
Approved
Time to decision
179 days
Received Dec 29, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P970004-S187
- Device name
- VERIFY EVALUATION SYSTEM FOR INTERSTIM THERAPY FOR URINARY CONTROL AND BOWEL CONTROL
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Dec 29, 2014
- Decided
- Jun 26, 2015
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P970004
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5270
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE MODEL 3579 CABLE AND MODEL 3676 CABLE AND ASSOCIATED CHANGES TO ENABLE USE OF THE APPROVED VERIFY¿ EVALUATION SYSTEM WITH THE APPROVED TEMPORARY TEST STIMULATION LEADS.
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.